These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2114615)

  • 21. [Effect of chemotherapy on the Schistosoma mansoni eggs].
    dos Reis MG; Andrade ZA
    Mem Inst Oswaldo Cruz; 1987; 82(2):161-5. PubMed ID: 3147355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Action of oxamniquine on Schistosoma mansoni in mice experimentally infected with a strain from Kenya].
    Kohn A; Bruce J; Kinoti G; Mutahi WT; Coles G; Katz N
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():361. PubMed ID: 3151113
    [No Abstract]   [Full Text] [Related]  

  • 23. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice.
    Silva LM; Menezes RM; de Oliveira SA; Andrade ZA
    Rev Soc Bras Med Trop; 2003; 36(3):335-41. PubMed ID: 12908033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lethal effect of oxamniquine and praziquantel on mice experimentally infected with Schistosoma mansoni.
    Tonelli SM; Goulart EM; Tonelli E; Coelho PM
    Rev Inst Med Trop Sao Paulo; 1995; 37(4):361-3. PubMed ID: 8599068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R; Pinto PL; de Sant'Ana EJ; Moreira AA; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):201-3. PubMed ID: 3135570
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preparation and characterization of prodrugs of the potential schistosomicid praziquantel].
    Riera de Narváez AJ; Araujo S
    Acta Cient Venez; 1988; 39(5-6):451-6. PubMed ID: 3270297
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
    Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
    Fallon PG; Hamilton JV; Doenhoff MJ
    Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
    Farid A; Malek AA; Rabie I; Helmy A; El Amir AM
    Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of oxamniquine on Schistosoma mansoni in experimentally infected mice].
    Kohn A; Serapiao CJ; Katz N; Dias EP
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):217-27. PubMed ID: 549207
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxamniquine in the prevention of bilharzial infection.
    Jewsbury JM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):18-20. PubMed ID: 606372
    [No Abstract]   [Full Text] [Related]  

  • 34. Schistosoma mansoni: acquired immunity in mice after the use of oxamniquine at the evolutive skin and pulmonary phases.
    Coelho PM; Mello RT; Gerken SE
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):28-31. PubMed ID: 1843393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.
    Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM
    Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.
    Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
    Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imbalance of Steroid Hormones in Hamsters Infected with
    Oliveira KC; Cardoso R; Dos Santos AC; Fernandes R; Botelho MC
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1122-1126. PubMed ID: 31142253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis.
    Pugh RN; Teesdale CH
    Br Med J (Clin Res Ed); 1983 Sep; 287(6396):877-8. PubMed ID: 6412867
    [No Abstract]   [Full Text] [Related]  

  • 39. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schistosoma mansoni: the survival and reproductive status of mature infections in mice treated with oxamniquine.
    Popiel I; Erasmus DA
    J Helminthol; 1982 Sep; 56(3):257-61. PubMed ID: 7175165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.